These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6150234)

  • 1. HLA C associations with acute leukaemia.
    D'Amaro J; Bach FH; Van Rood JJ; Rimm AA; Bortin MM
    Lancet; 1984 Nov; 2(8413):1176-8. PubMed ID: 6150234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA associations with leukemia.
    Bortin MM; D'Amaro J; Bach FH; Rimm AA; van Rood JJ
    Blood; 1987 Jul; 70(1):227-32. PubMed ID: 3474040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-Cw4 association with acute lymphoblastic leukaemia in Sicilian patients.
    Caruso C; Cammarata G; Sireci G; Modica MA
    Vox Sang; 1988; 54(1):57-8. PubMed ID: 3162341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I and class II antigen associations in acute leukaemias.
    Navarrete C; Alonso A; Awad J; McCloskey D; Ganesan TS; Amess J; Lister TA; Festenstein H
    J Immunogenet; 1986; 13(2-3):77-84. PubMed ID: 3469278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More familial leukaemia in ALL patients with both unexplained high transcortin levels and an HLA antigen Cw3.
    De Moor P; Boogaerts M; Louwagie A
    Br J Haematol; 1988 Jun; 69(2):225-7. PubMed ID: 3164632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA CW3 and HLA CW4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients.
    Rosas-Cabral A; Irigoyen L; Alvarado L; Vela-Ojeda J; Ayala-Sánchez M; Tripp-Villanueva F; Sánchez E; Gonzalez-Llaven J; Gariglio P
    Rev Invest Clin; 2003; 55(4):423-8. PubMed ID: 14635607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation.
    Chan KW; Pollack MS; Braun D; O'Reilly RJ; Dupont B
    Transplantation; 1982 Jun; 33(6):613-5. PubMed ID: 6954756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report from the International Bone Marrow Transplant Registry, 1984.
    Exp Hematol; 1985 Aug; 13(7):709-14. PubMed ID: 3896831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between leucocyte group-5a antigen and acute lymphoblastic leukaemia.
    Warren RP; Nguyen DD; Storb R; Thomas ED
    Lancet; 1977 Mar; 1(8010):509-10. PubMed ID: 65610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia.
    von Fliedner VE; Sultan Khan Z; Jeannet M
    Acta Haematol; 1981; 65(2):73-8. PubMed ID: 6785965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukaemia.
    Dickson A
    Acta Haematol; 1975; 54(3):143-51. PubMed ID: 809957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA and leukemia].
    Baldauf C; Kubel M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):123-32. PubMed ID: 2472315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation in leukemia.
    Kolb HJ
    Recent Results Cancer Res; 1984; 93():269-89. PubMed ID: 6382484
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia.
    Cohen E; Singal DP; Khurana U; Gregory SG; Cox C; Sinks L; Henderson E; Fitzpatrick JE; Higby D
    Prog Clin Biol Res; 1977; 16():65-70. PubMed ID: 269457
    [No Abstract]   [Full Text] [Related]  

  • 15. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia.
    Mizuno S; Emi N; Kasai M; Ishitani A; Saito H
    Br J Haematol; 2000 Oct; 111(1):280-2. PubMed ID: 11091213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigen CW3 combined with unexplained high transcortin levels is found in patients with acute lymphoblastic leukemia but not in their parents, sibs and offspring.
    de Moor P; Louwagie A
    J Steroid Biochem; 1986 Oct; 25(4):489-90. PubMed ID: 3464809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukaemia-associated antigen (LAA) in proliferative blood disorders.
    Stavem P; Berg K; Noer G
    Scand J Haematol; 1977 Jan; 18(1):13-9. PubMed ID: 265091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA system in acute leukaemia and Hodgkin's disease.
    Harris R; Lawler SD; Oliver RT
    Br Med Bull; 1978 Sep; 34(3):301-4. PubMed ID: 363226
    [No Abstract]   [Full Text] [Related]  

  • 19. The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines.
    Billing RJ; Terasaki PI; Honig R; Peterson P
    Lancet; 1976 Jun; 1(7974):1365-7. PubMed ID: 59011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for leukaemia in Europe. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation.
    Lancet; 1988 Jun; 1(8599):1379-82. PubMed ID: 2898053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.